Cargando…
Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by (111)In‐labeled Chimeric Monoclonal Antibody Nd2
The present study was carried out with the purpose of evaluating the clinical usefulness of radioimmunodetection (RAID) with (111)In‐labeled murine/human chimeric monoclonal antibody, Nd2 (c‐Nd2) in patients with pancreatic cancer. Nineteen patients suspected to have pancreatic cancer were administe...
Autores principales: | Sawada, Tetsuji, Nishihara, Tamahiro, Yamamoto, Atsushi, Teraoka, Hitoshi, Yamashita, Yoshito, Okamura, Terue, Ochi, Hironobu, Ho, Jenny J. L., Kim, Young‐Sik, Hirakawa, Kosei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926001/ https://www.ncbi.nlm.nih.gov/pubmed/10595748 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00693.x |
Ejemplares similares
-
Radioimmunodetection with (111)In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer
por: Chung, Yong‐Suk, et al.
Publicado: (1997) -
Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer
por: Nishihara, Tamahiro, et al.
Publicado: (2000) -
Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond
por: Garousi, Javad, et al.
Publicado: (2020) -
The Role of PAM4 in the Management of Pancreatic Cancer: Diagnosis, Radioimmunodetection, and Radioimmunotherapy
por: Han, Suxia, et al.
Publicado: (2014) -
Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.
por: Ind, T. E., et al.
Publicado: (1994)